Pharmacore

Pharmacore company information, Employees & Contact Information

Updated May 2026

Quick answer

Pharmacore is a Pharmaceutical Manufacturing company and founded in 1981. It has approximately 92 employees on record. Contact data was last refreshed in May 2026. Find Pharmacore's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

We’ve moved! For company news and updates follow Cambrex.

Company Details

Employees
92
Founded
-
Address
1 Meadowlands Plaza, East Rutherford,new Jersey 07073,united States
Phone
(336)841-5250
Email
in****@****ore.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
East Rutherford, New Jersey
Looking for a particular Pharmacore employee's phone or email?

Pharmacore Questions

News

Cambrex Commits $120 Million to Grow US API Manufacturing - Pharmaceutical Commerce

Cambrex Commits $120 Million to Grow US API Manufacturing Pharmaceutical Commerce

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply - Yahoo Finance

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply Yahoo Finance

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts - PR Newswire

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts PR Newswire

Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA Submission - Nasdaq

Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA Submission Nasdaq

Cambrex to Acquire Halo Pharma - CHEManager

Cambrex to Acquire Halo Pharma CHEManager

Permira seeks $4bn for sale of contract drugmaker Cambrex - Financial Times

Permira seeks $4bn for sale of contract drugmaker Cambrex Financial Times

Permira seeks $4 billion for sale of contract drugmaker Cambrex - PharmaLive

Permira seeks $4 billion for sale of contract drugmaker Cambrex PharmaLive

A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix | Organic Process Research & Development - ACS Publications

A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix | Organic Process Research & Development ACS Publications

Permira targets $4bn Cambrex exit - Private Equity Wire

Permira targets $4bn Cambrex exit Private Equity Wire

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing - PR Newswire

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing PR Newswire

Cambrex doubles liquid packaging capacity and weekly output at its Québec facility - News-Medical

Cambrex doubles liquid packaging capacity and weekly output at its Québec facility News-Medical

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash - GlobeNewswire

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash GlobeNewswire

Cambrex looks to fill 'onshore' API manufacturing demand with $50M expansion in Iowa - Fierce Pharma

Cambrex looks to fill 'onshore' API manufacturing demand with $50M expansion in Iowa Fierce Pharma

Cambrex completes $38 million expansion in North Carolina - Chemical & Engineering News

Cambrex completes $38 million expansion in North Carolina Chemical & Engineering News

Cambrex to pump $30M into expanding North Carolina manufacturing site - Fierce Pharma

Cambrex to pump $30M into expanding North Carolina manufacturing site Fierce Pharma

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific - PR Newswire

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific PR Newswire

Cambrex wraps up expansion of Snapdragon API plant in Massachusetts - Fierce Pharma

Cambrex wraps up expansion of Snapdragon API plant in Massachusetts Fierce Pharma

Technology Transfer and Process Development of Danicopan to Enable Process Validation - ACS Publications

Technology Transfer and Process Development of Danicopan to Enable Process Validation ACS Publications

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule - PR Newswire

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule PR Newswire

Cambrex Announces Sale of Drug Product Business Unit - PR Newswire

Cambrex Announces Sale of Drug Product Business Unit PR Newswire

Snapdragon rebounds with a deal to be acquired by Cambrex - Chemical & Engineering News

Snapdragon rebounds with a deal to be acquired by Cambrex Chemical & Engineering News

Cambrex opening new high-potency API facility in U.S. - Fierce Pharma

Cambrex opening new high-potency API facility in U.S. Fierce Pharma

CDMO Cambrex flips its aggressive buyout script with $2B sale to Permira Funds - Fierce Pharma

CDMO Cambrex flips its aggressive buyout script with $2B sale to Permira Funds Fierce Pharma

Permira prepares $4bn Cambrex exit as contract drugmakers attract investors - Private Equity Insights

Permira prepares $4bn Cambrex exit as contract drugmakers attract investors Private Equity Insights

Cambrex adds continuous manufacturing to sites in U.S. and Europe - Fierce Pharma

Cambrex adds continuous manufacturing to sites in U.S. and Europe Fierce Pharma

Cambrex adds Avista Pharma to the fold in $250M deal - Fierce Pharma

Cambrex adds Avista Pharma to the fold in $250M deal Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma - Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma Fierce Pharma

Permira Snaps Up Cambrex in Deal Valued at $2.4 Billion - BioSpace

Permira Snaps Up Cambrex in Deal Valued at $2.4 Billion BioSpace

Deal Roundup: Permira said to eye $4bn valuation through Cambrex sale, PAI agrees Marcolin exit to VSP Vision - AltAssets Private Equity News

Deal Roundup: Permira said to eye $4bn valuation through Cambrex sale, PAI agrees Marcolin exit to VSP Vision AltAssets Private Equity News

Cambrex buying Pharmacore in $25M deal - Fierce Pharma

Cambrex buying Pharmacore in $25M deal Fierce Pharma

Cambrex completes US$38 million capacity expansion in High Point, North Carolina - Indian Pharma Post

Cambrex completes US$38 million capacity expansion in High Point, North Carolina Indian Pharma Post

Cambrex Acquires Q1 Scientific in Waterford - businessplus.ie

Cambrex Acquires Q1 Scientific in Waterford businessplus.ie

Methods to Develop and Validate Bioassays - Genetic Engineering and Biotechnology News

Methods to Develop and Validate Bioassays Genetic Engineering and Biotechnology News

Lonza Makes Its Largest Acquisition: Cambrex’ Bio Businesses for $460M - Genetic Engineering and Biotechnology News

Lonza Makes Its Largest Acquisition: Cambrex’ Bio Businesses for $460M Genetic Engineering and Biotechnology News

Top Pharmacore Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant